Section Arrow
ANIK.NASDAQ
- Anika Therapeutics
Quotes are at least 15-min delayed:2025/02/23 01:14 EST
Last
 17.39
-0.26 (-1.47%)
Day High 
17.805 
Prev. Close
17.65 
1-M High
18.37 
Volume 
51.66K 
Bid
17.39
Ask
17.42
Day Low
17.39 
Open
17.75 
1-M Low
15.93 
Market Cap 
258.49M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 17.74 
20-SMA 17.39 
50-SMA 16.82 
52-W High 29.115 
52-W Low 15.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.64/0.62
Enterprise Value
285.40M
Balance Sheet
Book Value Per Share
12.28
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
166.66M
Operating Revenue Per Share
11.15
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 01:14 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.